Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “HIV”

Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEXRecruiting
NCT07505875N/AUpdated Apr 6, 2026
Sponsor: Institute of HIV Research and Innovation Foundation, Thailand
Substance Use · HIV Prevention · Sexually Transmitted Infections (STIs)
Thailand
Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)Completed
NCT04597424Phase 3Updated Apr 6, 2026
Sponsor: ANRS, Emerging Infectious Diseases
Unsafe Sex · Risk-Taking
France
eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood IllnessCompleted
NCT04150120NAUpdated Apr 6, 2026
Sponsor: Lund University
Preterm Birth · Pediatric Cancer · Hirschsprung Disease · Congenital Malformation
Denmark, Ethiopia, Sweden
Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral LoadCompleted
NCT00454337Phase 3Updated Apr 6, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections
France
Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune RestorationCompleted
NCT00944541Phase 2Updated Apr 6, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infection · HIV Infections
France
ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIVCompleted
NCT00901524Phase 2Updated Apr 6, 2026
Sponsor: ANRS, Emerging Infectious Diseases
Hepatitis
France
Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGWCompleted
NCT04760691Phase 1Updated Apr 6, 2026
Sponsor: Johns Hopkins University
HIV · Prophylaxis · Transgender
United States
Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected PatientsCompleted
NCT00480792Phase 3Updated Apr 6, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV Infections
France
Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and TruvadaCompleted
NCT00528060Phase 2Updated Apr 6, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections
France
Propranolol for the Treatment of Kaposi Sarcoma in AdultsRecruiting
NCT06445166Phase 2Updated Apr 6, 2026
Sponsor: Washington University School of Medicine
Kaposi Sarcoma
United States
Raltegravir in Patients With End Stage Liver Disease and in Transplant RecipientsCompleted
NCT01022476Phase 1, Phase 2Updated Apr 6, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV Infection · Liver Failure · Evidence of Liver Transplantation
France
The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)Recruiting
NCT07512856NAUpdated Apr 6, 2026
Sponsor: Institute of HIV Research and Innovation Foundation, Thailand
HIV Prevention · Substance Use · Mental Health Disorders · Sexually Transmitted Infections (STIs)
Thailand
Entre Herman@s: Promoting Health Among Latino MSMCompleted
NCT05805306NAUpdated Apr 6, 2026
Sponsor: Charles Drew University of Medicine and Science
HIV Infections
United States
South Africa Smoking Cessation and Engagement in HIV/TB Care CareRecruiting
NCT05842161NAUpdated Apr 6, 2026
Sponsor: Massachusetts General Hospital
HIV Infections · Tuberculosis · Smoking Cessation
South Africa
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ StudyRecruiting
NCT05769218NAUpdated Apr 6, 2026
Sponsor: Boston Medical Center
Opioid Use Disorder
United States
Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation StudyRecruiting
NCT07512869N/AUpdated Apr 6, 2026
Sponsor: Institute of HIV Research and Innovation Foundation, Thailand
HIV Prevention · Substance Use · Mental Health · Sexually Transmitted Infections (STIs)
Thailand
Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)Completed
NCT00120757Phase 3Updated Apr 3, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Osteoporosis · HIV Infections
France
Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 PatientsCompleted
NCT02384967Phase 2Updated Apr 3, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV INFECTION
France
California MEPS HubRecruiting
NCT07433985NAUpdated Apr 3, 2026
Sponsor: University of California, Los Angeles
HIV Prevention · Sexually Transmitted Infections (STI) · Preexposure Prophylaxis (PrEP) · Incarceration
United States
Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)Recruiting
NCT07509827NAUpdated Apr 3, 2026
Sponsor: Institute of HIV Research and Innovation Foundation, Thailand
HIV Prevention · HIV Related Stigma · PrEP Adherence
Thailand
Evaluation of Long-Acting Injectable (LAI) and Teen Clubs in Adolescents (ATTUNE).Recruiting
NCT06721078NAUpdated Apr 3, 2026
Sponsor: Africa Health Research Institute
Hiv
South Africa
Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)Completed
NCT00120185Phase 2Updated Apr 3, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections
France
Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRALCompleted
NCT02212379Phase 2Updated Apr 3, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV-1 Infection
France, Spain
Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)Completed
NCT00117494Phase 4Updated Apr 3, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Hyperlipidemia · HIV Infections
France
Engaging Pharmacists to Advance Tobacco Treatment Service DeliveryEnrolling By Invitation
NCT07501624NAUpdated Apr 3, 2026
Sponsor: Medical University of South Carolina
Smoking Cessation · Tobacco Use Disorder · Smoking · HIV
United States

Previous page Next page